Health
Researchers develop a nanoparticle-based formulation with anti-SARS-CoV-2 activity – News-Medical.Net
A study recently published in the journal Matter has demonstrated the development and validation of a nanoparticle-based formulation, capable of completely inhibiting…
A study recently published in the journal Matter has demonstrated the development and validation of a nanoparticle-based formulation, capable of completely inhibiting the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection blocking the interaction between viral spike protein and host cell angiotensin-converting enzyme 2 (ACE2).
Background
SARS-CoV-2, the causative pathogen of coronavirus disease 2019 (COVID-19), is an enveloped, single-stranded, positive-sense RNA virus belonging…
-
General14 hours agoWoman in her 20s dies after dog attack in Western Australia’s north
-
Noosa News23 hours agoDicky Bill salad greens farms enter administration with 180 job cuts just before Christmas
-
General20 hours agoGold Coast warned it faces traffic gridlock without major shift to public transport
-
General24 hours agoAlbanese reached his zenith in 2025, but 2026 could test the limits of Labor’s power